T. Rowe Price Associates’s AIM ImmunoTech Inc. AIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-203
| Closed | -$9K | – | 3040 |
|
|
2023
Q1 | $9K | Sell |
203
-954
| -82% | -$42.3K | ﹤0.01% | 2887 |
|
|
2022
Q4 | $36K | Hold |
1,157
| – | – | ﹤0.01% | 2849 |
|
|
2022
Q3 | $68K | Sell |
1,157
-11
| -0.9% | -$646 | ﹤0.01% | 2789 |
|
|
2022
Q2 | $91K | Hold |
1,168
| – | – | ﹤0.01% | 2766 |
|
|
2022
Q1 | $124K | Hold |
1,168
| – | – | ﹤0.01% | 2806 |
|
|
2021
Q4 | $107K | Hold |
1,168
| – | – | ﹤0.01% | 2860 |
|
|
2021
Q3 | $236K | Hold |
1,168
| – | – | ﹤0.01% | 2655 |
|
|
2021
Q2 | $251K | Hold |
1,168
| – | – | ﹤0.01% | 2637 |
|
|
2021
Q1 | $265K | Hold |
1,168
| – | – | ﹤0.01% | 2597 |
|
|
2020
Q4 | $209K | Hold |
1,168
| – | – | ﹤0.01% | 2544 |
|
|
2020
Q3 | $251K | Buy |
+1,168
| New | +$251K | ﹤0.01% | 2351 |
|